Suppressor T cells and soluble suppressor factors in allergy: effect of immunotherapy

Clin Allergy. 1984 Nov;14(6):519-24. doi: 10.1111/j.1365-2222.1984.tb02238.x.

Abstract

Suppressor-cell activity of Concanavalin-A-stimulated lymphocytes was studied in allergic patients by inhibition of one-way mixed lymphocyte culture reactions before and after allergy immunotherapy. This activity was compared with twelve healthy controls. In preliminary experiments, six out of eight allergic patients had no detectable T suppressor activity. In the second prospective group, eight out of eleven patients had much reduced suppressor-cell activity before immunotherapy, and seven out of eleven patients had much reduced activity after immunotherapy. The data suggest that non-specific T suppressor-cell activity is reduced in allergic patients but immunotherapy does not restore such activity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Female
  • Humans
  • Hypersensitivity / immunology
  • Hypersensitivity / therapy*
  • Immunotherapy
  • Lymphocyte Culture Test, Mixed
  • Lymphokines / biosynthesis*
  • Male
  • Suppressor Factors, Immunologic
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • Lymphokines
  • Suppressor Factors, Immunologic